Dan O'Connell Email & Phone Number

Boston, MA, US

Concord, Massachusetts, United States

Concord, Massachusetts, United States

Promoted into position by SVP of Global MS Business Unit to lead Global Franchise marketing across all products including leading engagements with Operational Leadership Committee (Regional Presidents) and Executive Committee

Appointed by SVP of Global MS Business Unit to lead TYSABRI Global product team, including managing one direct report, during a period of transition. Responsible for leading Global Cross-functional team including dotted line reporting of R&D, Manufacturing, Medical, Regulatory, and Value & Access. Accomplishments included Managed one direct report during.

Accepted lateral position to lead Global Commercial Strategy for key MS therapy with 2 direct reports through period of launch of subcutaneous formulation and publication of key, label-enabling data

Appointed to return to aducanumab (ADUHELM) Global Commercial team in an individual contributor role by VP of Alzheimer’s Business Unit after reformation of team

Promoted into role by VP, Head of MS Global Business Unit following declaration of futility for Alzheimer’s therapy (aducanumab) to lead Global Commercial Strategy for flagship MS therapy with one direct report

Hired into role at recommendation of VP of US Rare Disease to work on key therapy for Global Organization reporting to Global Commercial Lead in an individual contributor role

Promoted into role to establish East Region (east coast of United States) team of 8 direct reports for Rare Disease launch product

Weston, MA

Appointed by VP of US Marketing as first US Marketer to newly developed Rare Disease Franchise for development of positioning and go-to-market model for Spinal Muscular Atrophy (SMA) therapy, SPINRAZA

Weston, MA

Hired into an individual contributor role reporting to US TYSABRI Brand Lead to drive marketing to HCPs treating multiple sclerosis with TYSABRI

Cambridge, MA

Promoted by group Vice President into US Marketing leadership role for launch of key Rare Disease therapy including Marketing Strategy and launch planning

Cambridge, MA

Hired into a Global marketing role leading Disease State and Branded campaign development for a pre-launch product

Appointed by Regional President as Brand Team representative responsible for liaising with Regional Business Units driving inline growth of Celebrex & Lyrica

Promoted by Sr Marketing Director to lead development and implementation of innovation-based initiatives across the US Primary Care marketing group. Core team member developing guiding strategy for emerging organized customer base (ACO, PCMH, medical groups, and integrated delivery systems)

Core team member of the Multi-Channel/Closed Loop Marketing (CLM) team including Communication, Change Management, and Training for implementation of Closed Loop marketing system across all Field Sales teams (5,000 representatives and sales leaders)

Mba, Marketing

Bs, Business Administration